Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-07-31
2007-07-31
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S428000, C514S237800, C514S241000, C514S252120, C514S252100, C514S256000, C514S331000, C514S357000, C514S365000, C514S374000, C514S383000, C514S399000, C514S406000, C514S427000, C548S235000, C548S255000, C548S204000, C548S267200
Reexamination Certificate
active
10514303
ABSTRACT:
The present invention is directed to water-soluble derivatives of 2,6-diisopropylphenol (Propofol). The compounds act as prodrugs of 2,6-diisopropylphenol and metabolize rapidly to Propofol thereby providing an alternative to the water-insoluble 2,6-diisopropylphenol. Pharmaceutical compositions comprising these compounds, methods of induction and maintenance of anesthesia or sedation as well as methods of treating neurodegenerative diseases utilizing pharmaceutical compositions comprising these compounds and methods of preparing them are also disclosed.
REFERENCES:
patent: 6204257 (2001-03-01), Stella et al.
patent: 6254853 (2001-07-01), Hendler et al.
patent: 6362234 (2002-03-01), Hendler et al.
patent: 6872838 (2005-03-01), Stella et al.
patent: 2002-275065 (2002-09-01), None
patent: WO 9115464 (1991-10-01), None
Banaszczyk et al., “Propofol Phosphate, a Water-Soluble Propofol Prodrug: In Vivo Evaluation,” Anesth. Analog, 2002, vol. 95, pp. 1285-92.
Sliskovic et al., “Inhibitors of Acyl-CoA: Cholesterol 0-Acyl Transferase (ACAT) as Hypocholesterolemic Agents. The Synthesis and Biological Activity of a Series of Malonester Amides,” Bioorganic & Medicinal Chemistry Letters, 1996, 6:6, pp. 713-718.
Bennett et al., “Novel Water Soluble 2,6-Dimethoxyphenyl Ester Derivatives with Intravenous Anaesthetic Activity,” Bioorganic & Medicinal Chemistry Letters, vol. 13, 2003, pp. 1971-1975.
Trapani et al., “Water-soluble salts of aminoacid esters of the anaesthetic agent Propofol”, International Journal of Pharmaceutics, vol. 175, 1998, pp. 195-204.
Sohma et al., “Development of Water-Soluble Prodrugs of the HIV-1 Protease Inhibitor KNI-727: Importance of the Conversion Time for Higher Gastrointestinal Absorption of Prodrugs Based on Spontaneous Chemical Cleavage,” J. Med. Chem., 2003, vol. 46, pp. 4124-4135.
Fechner et al., “Pharmacokinetics and Clinical Pharmacodynamics of the New Propofol Prodrug GPI 15715 in Volunteers,” Anesthesiology, 2003, vol. 99, pp. 303-313.
Lee et al., “Inhibitors of ACYL-CoA: Cholesterol O-Acyltransferase (ACAT) as Hypocholesterolemic Agents: Synthesis and Structure-Activity Relationships of Novel Series of Sulfonamides, Acylphosphonamides and Acylphosphoramidates,” Bioorganic and Medicinal Chemistry Letters, vol. 8, 1998, pp. 289-294.
Altomare et al., “Highly water-soluble derivatives of the anesthetic agent propofol: in vitro and in vivo evaluation of cyclic amino acid esters,” European Journal of Pharmceutical Sciences, vol. 20, 2003, pp. 17-26.
Trapani et al., “Propofol Analogues. Synthesis, Relationshis between Structure and Affinity at GABAA Receptor in Rat Brain, and Differential Electrophysiological Profile at Recombinant Human GABAA Receptors”, J. Med. Chem 1998, vol. 41, 1846-1854.
Lee et al., “Phenolic Modification as an Approach to Improve the Pharmacology of the 3-Acyloxy-2-benzylpropyl Homovanillic Amides and Thioureas, a Promising Class of Vanilloid Receptor Agonists and Alagesics”, Bioorg. & Medic. Chem., vol. 10, 2002, pp. 1171-1179.
Cooke et al., “Water-Soluble Propofol Analogues with Intravenous Anaesthetic Activity”, Bioorganic and Medicinal Chemistry Letters, vol. 11, 2001, pp. 927-930.
Trapani et al., “Effect of 2-hydroxypropyl-beta-cyclodextrin on the aqueous solubility of the anaesthetic agent propofol (2,6-diisopropylphenol)”, International Journal of Pharmaceutics, vol. 139, 1996, pp. 215-218.
Anderson et al., “alpha-amino Acid Phenolic Ester Derivatives: Novel Water-Soluble General Anesthetic Agents Which Allosterically Modulate GABAA Receptors”, J. Med. Chem, 2001, vol. 44, pp. 3582-3591.
Davenport Cris
Marappan Subramanian
Sarshar Sepehr
Auspex Pharmaceuticals, Inc.
Barker Michael P.
DLA Piper (US) LLP
Saeed Kamal A.
LandOfFree
PH sensitive prodrugs of 2,6-Diisopropylphenol does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with PH sensitive prodrugs of 2,6-Diisopropylphenol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PH sensitive prodrugs of 2,6-Diisopropylphenol will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3725046